| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Clone-specific MYD88 L265P and CXCR4 mutation status can provide clinical utility in suspected Waldenström macroglobulinemia/lymphoplasmacytic lymphoma
|
Burnworth, Bettina
|
|
2016
|
51 |
C |
p. 41-48
8 p.
|
artikel
|
| 2 |
Combination of RNA- and exome sequencing: Increasing specificity for identification of somatic point mutations and indels in acute leukaemia
|
Hansen, Marcus C.
|
|
2016
|
51 |
C |
p. 27-31
5 p.
|
artikel
|
| 3 |
Editorial board and publication information
|
|
|
2016
|
51 |
C |
p. IFC-
1 p.
|
artikel
|
| 4 |
Fenretinide targets the side population in myeloma cell line NCI-H929 and potentiates the efficacy of antimyeloma with bortezomib and dexamethasone regimen
|
Yan, Wenqing
|
|
2016
|
51 |
C |
p. 32-40
9 p.
|
artikel
|
| 5 |
Good riddance to the term “refractory anemia” in myelodysplastic syndromes
|
Steensma, David P.
|
|
2016
|
51 |
C |
p. 22-26
5 p.
|
artikel
|
| 6 |
Green tea polyphenol “epigallocatechin-3-gallate”, differentially induces apoptosis in CLL B-and T-Cells but not in healthy B-and T-Cells in a dose dependant manner
|
Cornwall, Scott
|
|
2016
|
51 |
C |
p. 56-61
6 p.
|
artikel
|
| 7 |
Increased TIM3+CD8+T cells in Myelodysplastic Syndrome patients displayed less perforin and granzyme B secretion and higher CD95 expression
|
Tao, Jinglian
|
|
2016
|
51 |
C |
p. 49-55
7 p.
|
artikel
|
| 8 |
Low ABCB1 and high OCT1 levels play a favorable role in the molecular response to imatinib in CML patients in the community clinical practice
|
da Cunha Vasconcelos, Flavia
|
|
2016
|
51 |
C |
p. 3-10
8 p.
|
artikel
|
| 9 |
Myelodysplastic syndromes: Aiming at deciphering their secrets
|
Diamantidis, Michael D.
|
|
2016
|
51 |
C |
p. 1-2
2 p.
|
artikel
|
| 10 |
Switching to nilotinib in patients with chronic myeloid leukemia in chronic phase with molecular suboptimal response to frontline imatinib: SENSOR final results and BIM polymorphism substudy
|
Miyamura, Koichi
|
|
2016
|
51 |
C |
p. 11-18
8 p.
|
artikel
|
| 11 |
Why do subjects on clinical trials discontinue therapy? Do we really know?
|
Medeiros, Bruno C.
|
|
2016
|
51 |
C |
p. 19-21
3 p.
|
artikel
|
Tijdschrift beschrijving